DEA Archived Press Releases

Press Releases before January 20, 2025
19 Results - Showing 1 to 10
PRESS RELEASE

Drug Enforcement Administration Set to Recruit and Educate at the College World Series ™ in Omaha

OMAHA, Neb. – Members of the Drug Enforcement Administration (DEA) will be in Baseball Village during the College World Series ™ recruiting and providing information on the dangers of fentanyl and other drugs seen frequently in communities across the nation. The DEA booth is located on the east side of...
PRESS RELEASE

Former Guinea-Bissau President’s Son Sent to U.S. prison for International Drug Trafficking

HOUSTON – The leader of a transnational drug trafficking organization has been imprisoned for his involvement in an international heroin trafficking conspiracy, announced Drug Enforcement Administration Special Agent in Charge Daniel C. Comeaux, Houston Division and U.S. Attorney Alamdar S. Hamdani. Malam Bacai Sanha Jr., 52, pleaded guilty Sept. 6...
PRESS RELEASE

DEA El Paso Hiring Special Agents to Work in Local Offices

EL PASO – On Monday Feb. 26 beginning at midnight, t he Drug Enforcement Administration’s El Paso Division will be accepting applications for Special Agents to work in one of five local offices: El Paso, Midland, or Alpine, Texas or Las Cruces, Roswell, or Albuquerque, New Mexico. Upon completion of...
PRESS RELEASE

DEA Dedicates September 11th Memorial

WASHINGTON - On Friday, September 9, 2022, the Drug Enforcement Administration dedicated a memorial at DEA Headquarters in Arlington, Virginia to DEA New York Drug Enforcement Task Force Officers who have lost their lives from illness or disease caused by their work at Ground Zero after the terrorist attacks of...
PRESS RELEASE

DEA Washington Division Releases 2020 National Drug Threat Assessment for D.C., Maryland, and Virginia Communities

Washington, D.C. – Today, DEA Acting Administrator D. Christopher Evans, and Special Agent in Charge of the DEA Washington Division, Jarod Forget, announce the release of the 2020 National Drug Threat Assessment – DEA’s annual publication outlining the threats posed to the U.S. by domestic and international drug trafficking and...
PRESS RELEASE

Fentanyl and heroin darknet vendors indicted

SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...